TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Mylan adds generic Detrol, HIV/AIDS drugs

MYL $27.29 +$0.10

at close on THURSDAY

Daily Photo Galleries

Thursday, Nov. 29, 2012, 12:40 p.m.
 

Mylan Inc. said on Thursday that it had introduced a generic incontinence drug to the U.S. market and was selected by the South African government as a supplier of antiretroviral drugs.

Cecil-based Mylan has started selling Tolterodine Tartrate tablets, the generic version of Detrol, made by Pfizer Inc. Tolterodine Tartrate had U.S. sales of $61.5 million for the 12 months ended Sept. 30.

The company said the South African National Department of Health selected Mylan's Indian subsidiary to supply it with 31 percent of the 30 million units of HIV/AIDS drugs it will buy in a two-year period ending Dec. 31, 2014.

Mylan's share of the contract is valued at about $127.5 million.

Add Alex Nixon to your Google+ circles.

 

 

 
 


Show commenting policy

Most-Read Stories

  1. Pirates inquire about Red Sox LHP Lester
  2. Starkey: Would one big move kill Pirates’ future?
  3. Rivers Casino sued by family of patron who died in car crash
  4. Gaza’s only power plant taken out; utility official says attack ‘catastrophic’ for 1.8 million
  5. ‘I-word’ pays off for Dems’ campaign
  6. Steelers offensive line hopes to build on strong 2013 finish
  7. Highway funding overhaul sought
  8. Former walk-ons may lose scholarships under Penn State’s Franklin
  9. Murrysville Legion pledges to rebound from opening-round loss at state tournament
  10. Last crew member of Enola Gay dies in Georgia
  11. Rostraver police issue warning after home invasion, robbery
Subscribe today! Click here for our subscription offers.